Equity Analysis

Quarterly Results

    Alpa Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    532878
    INE385I01010
    72.8658745
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    ALPA
    11.15
    199.35
    EPS(TTM)
    Face Value()
    Div & Yield %:
    8.5
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales27.3132.3925.43
Other Operating Income0.000.000.00
Other Income 3.552.954.47
Total Income30.8635.3529.90
Total Expenditure 24.8529.0826.58
PBIDT6.016.273.32
Interest 0.030.040.02
PBDT5.986.233.30
Depreciation0.660.490.28
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.790.000.00
Reported Profit After Tax4.535.743.03
Extra-ordinary Items 0.020.000.03
Adjusted Profit After Extra-ordinary item4.515.743.00
EPS (Unit Curr.)2.152.751.44
EPS (Adj) (Unit Curr.)2.152.751.44
Calculated EPS (Unit Curr.)2.152.731.44
Calculated EPS (Adj) (Unit Curr.)2.152.731.44
Calculated EPS (Ann.) (Unit Curr.)8.6110.915.75
Calculated EPS (Adj) (Ann.) (Unit Curr.)8.6110.915.75
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity21.0421.0421.04
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)22.0119.3613.06
PBDTM(%)21.9019.2312.98
PATM(%)16.5917.7211.92
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.152.751.44